Familial Adenomatous Polyposis
📧 Sign up to get email alerts when something new happens for Familial Adenomatous Polyposis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-04-24Clinical Trial Update: A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP) [Phase 3]
A Phase 3 trial evaluating low-dose sulindac combined with eflornithine for Familial Adenomatous Polyposis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-24Clinical Trial Update: Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis [Phase 2, Phase 3]
This clinical trial update notes that the Phase 2/3 study of Exisulind to prevent polyps in patients with familial adenomatous polyposis has…
-
CLINICAL_TRIALS withdrawal · 2012-09-20Clinical Trial Update: Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients [Phase 2]
Phase 2 trial of curcumin for the lower gastrointestinal tract in patients with familial adenomatous polyposis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-07-06Clinical Trial Update: Coxib-inhibition of Duodenal Polyp Growth in FAP [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating a COX-2 inhibitor (coxib) for reducing duodenal polyps in patients with familial adenomatous pol…